Cell BioEngines
Phase 1A global cellular medicine company headquartered in New York, USA focussed on developing proprietary ‘off-the-shelf’ allogenic cell therapies to cure cancer.
Founded
2022
Focus
RNA & Gene TherapyCell & Gene Therapy
About
A global cellular medicine company headquartered in New York, USA focussed on developing proprietary ‘off-the-shelf’ allogenic cell therapies to cure cancer.
Funding History
2Total raised: $37.2M
Series A$32MBioline VenturesMar 15, 2023
Seed$5.2MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2022
LocationCambridge, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile